MRF: Q2 CONS NET PROFIT 3.87B RUPEES VS 5.3B (YOY)
MRF: Q2 EBITDA 9.58B RUPEES VS 11.25B (YOY); Q2 EBITDA MARGIN 11.06% VS 15.26% (YOY)
MRF: Q2 REVENUE 86.6B RUPEES VS 73.8B (YOY)
MRF: Q2 EBITDA 9.58B RUPEES VS 11.25B (YOY); Q2 EBITDA MARGIN 11.06% VS 15.26% (YOY)
MRF: Q2 REVENUE 86.6B RUPEES VS 73.8B (YOY)
β€1
ARTSON: CO RECEIVES PURCHASE ORDER WORTH βΉ16.07 CR FROM TATA STEEL FOR SUPPLY OF DOME & REFORMER SHELL; ORDER TO BE EXECUTED BY MAY 6, 2027; TRANSACTION IS AT ARM'S LENGTH AND INVOLVES RELATED PARTY
IRB INFRA β Q4 FY26 (CONSOLIDATED)
β’ Net Profit: βΉ1,714 Cr | YoY β 10.50% | QoQ β 5.00%
β’ Revenue: βΉ1,714 Cr | YoY β 12.00% | QoQ β 5.00%
β’ EBITDA: βΉ1,520 Cr | YoY β 10.00% | QoQ β 5.00%
β’ EBITDA Margin: 88.68% vs 88.50% (YoY), 88.60% (QoQ)
Summary: Net Profit, Revenue and EBITDA registered growth on both YoY and QoQ basis.
β’ Net Profit: βΉ1,714 Cr | YoY β 10.50% | QoQ β 5.00%
β’ Revenue: βΉ1,714 Cr | YoY β 12.00% | QoQ β 5.00%
β’ EBITDA: βΉ1,520 Cr | YoY β 10.00% | QoQ β 5.00%
β’ EBITDA Margin: 88.68% vs 88.50% (YoY), 88.60% (QoQ)
Summary: Net Profit, Revenue and EBITDA registered growth on both YoY and QoQ basis.
DHP INDIA β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ526.36 Cr | YoY β 50.43% | QoQ β 12.08%
β’ Revenue: βΉ2,810.09 Cr | YoY β 48.55% | QoQ β 21.31%
β’ EBITDA: βΉ722.99 Cr | YoY β 145.28% | QoQ β 14.56%
β’ EBITDA Margin: 25.72% vs 10.97% (YoY), 26.83% (QoQ)
Summary: Strong revenue and EBITDA growth, but Net Profit declined YoY.
β’ Net Profit: βΉ526.36 Cr | YoY β 50.43% | QoQ β 12.08%
β’ Revenue: βΉ2,810.09 Cr | YoY β 48.55% | QoQ β 21.31%
β’ EBITDA: βΉ722.99 Cr | YoY β 145.28% | QoQ β 14.56%
β’ EBITDA Margin: 25.72% vs 10.97% (YoY), 26.83% (QoQ)
Summary: Strong revenue and EBITDA growth, but Net Profit declined YoY.
VARDHMAN HOLDINGS β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ111.44 Cr | YoY β 141.63% | QoQ β 13.62%
β’ Revenue: βΉ22.50 Cr | YoY β 718.18% | QoQ β 107.76%
β’ EBITDA: βΉ19.86 Cr | YoY β 730.96% | QoQ β 97.02%
β’ EBITDA Margin: 88.27% vs 86.91% (YoY), 93.07% (QoQ)
Summary: Strong growth in Net Profit, Revenue and EBITDA on both YoY and QoQ basis.
β’ Net Profit: βΉ111.44 Cr | YoY β 141.63% | QoQ β 13.62%
β’ Revenue: βΉ22.50 Cr | YoY β 718.18% | QoQ β 107.76%
β’ EBITDA: βΉ19.86 Cr | YoY β 730.96% | QoQ β 97.02%
β’ EBITDA Margin: 88.27% vs 86.91% (YoY), 93.07% (QoQ)
Summary: Strong growth in Net Profit, Revenue and EBITDA on both YoY and QoQ basis.
UNITED TEA β Q2 FY27 (STANDALONE)
β’ Net Profit: βΉ3.58 Cr | YoY β 27.40% | QoQ β 43.80%
β’ Revenue: βΉ22.76 Cr | YoY β 7.74% | QoQ β 14.82%
β’ EBITDA: βΉ3.52 Cr | YoY β 22.10% | QoQ β 30.76%
β’ EBITDA Margin: 15.44% vs 21.36% (YoY), 25.60% (QoQ)
Summary: Revenue grew, but Net Profit, EBITDA and margins declined.
β’ Net Profit: βΉ3.58 Cr | YoY β 27.40% | QoQ β 43.80%
β’ Revenue: βΉ22.76 Cr | YoY β 7.74% | QoQ β 14.82%
β’ EBITDA: βΉ3.52 Cr | YoY β 22.10% | QoQ β 30.76%
β’ EBITDA Margin: 15.44% vs 21.36% (YoY), 25.60% (QoQ)
Summary: Revenue grew, but Net Profit, EBITDA and margins declined.
π₯1
NILE β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ2.74 Cr | YoY β 76.52% | QoQ β 66.50%
β’ Revenue: βΉ221.66 Cr | YoY β 19.10% | QoQ β 21.04%
β’ EBITDA: βΉ5.48 Cr | YoY β 68.70% | QoQ β 48.16%
β’ EBITDA Margin: 2.47% vs 6.39% (YoY), 3.77% (QoQ)
Summary: Sharp decline in Net Profit, Revenue, EBITDA and margins on both YoY and QoQ basis.
β’ Net Profit: βΉ2.74 Cr | YoY β 76.52% | QoQ β 66.50%
β’ Revenue: βΉ221.66 Cr | YoY β 19.10% | QoQ β 21.04%
β’ EBITDA: βΉ5.48 Cr | YoY β 68.70% | QoQ β 48.16%
β’ EBITDA Margin: 2.47% vs 6.39% (YoY), 3.77% (QoQ)
Summary: Sharp decline in Net Profit, Revenue, EBITDA and margins on both YoY and QoQ basis.
HIRECT β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ6.82 Cr | YoY β 53.69% | QoQ β 27.63%
β’ Revenue: βΉ315.69 Cr | YoY β 38.98% | QoQ β 22.15%
β’ EBITDA: βΉ13.59 Cr | YoY β 47.49% | QoQ β 2.85%
β’ EBITDA Margin: 4.31% vs 11.40% (YoY), 5.11% (QoQ)
Summary: Revenue grew, but Net Profit and margins declined sharply.
β’ Net Profit: βΉ6.82 Cr | YoY β 53.69% | QoQ β 27.63%
β’ Revenue: βΉ315.69 Cr | YoY β 38.98% | QoQ β 22.15%
β’ EBITDA: βΉ13.59 Cr | YoY β 47.49% | QoQ β 2.85%
β’ EBITDA Margin: 4.31% vs 11.40% (YoY), 5.11% (QoQ)
Summary: Revenue grew, but Net Profit and margins declined sharply.
ROSSELL β Q2 FY27 (STANDALONE)
β’ Net Profit: βΉ27.28 Cr | YoY β 0.29% | QoQ β 616.01%
β’ Revenue: βΉ91.57 Cr | YoY β 13.26% | QoQ β 148.97%
β’ EBITDA: βΉ37.05 Cr | YoY β 12.92% | QoQ β 463.93%
β’ EBITDA Margin: 40.46% vs 40.58% (YoY), 17.86% (QoQ)
Summary: Strong QoQ recovery in Net Profit, Revenue and EBITDA, with margins improving sharply.
β’ Net Profit: βΉ27.28 Cr | YoY β 0.29% | QoQ β 616.01%
β’ Revenue: βΉ91.57 Cr | YoY β 13.26% | QoQ β 148.97%
β’ EBITDA: βΉ37.05 Cr | YoY β 12.92% | QoQ β 463.93%
β’ EBITDA Margin: 40.46% vs 40.58% (YoY), 17.86% (QoQ)
Summary: Strong QoQ recovery in Net Profit, Revenue and EBITDA, with margins improving sharply.
β€1
FEDβS WALLER BACKS DECEMBER RATE HIKE, SAYS OPEN TO 50 BPS MOVE
β€4π1
NMDC: CO IN TALKS WITH RUSSIA'S ROSATOM OVER POSSIBLE RUSSIAN LITHIUM INVESTMENTS, SOURCES SAY- RTRS
Suraksha Diagnostic Ltd β Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026:
- Q2 FY27 Total Income: INR 100.58 Cr (up 69% YoY)
- Q2 FY27 EBITDA: INR 36.32 Cr (up 45% YoY)
- Q2 FY27 Profit After Tax: INR 14.95 Cr (up 69% YoY)
- H1 FY27 Total Income: INR 189.31 Cr (up 24% YoY)
- H1 FY27 Profit After Tax: INR 27.8 Cr (up 54% YoY)
- Total Tests (H1 FY27): 4.42 million (up 7% YoY)
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026:
- Q2 FY27 Total Income: INR 100.58 Cr (up 69% YoY)
- Q2 FY27 EBITDA: INR 36.32 Cr (up 45% YoY)
- Q2 FY27 Profit After Tax: INR 14.95 Cr (up 69% YoY)
- H1 FY27 Total Income: INR 189.31 Cr (up 24% YoY)
- H1 FY27 Profit After Tax: INR 27.8 Cr (up 54% YoY)
- Total Tests (H1 FY27): 4.42 million (up 7% YoY)
β€2π1
AVANTIFEED β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ68.95 Cr | YoY β 55.02% | QoQ β 33.25%
β’ Revenue: βΉ1,752.52 Cr | YoY β 8.93% | QoQ β 7.76%
β’ EBITDA: βΉ78.02 Cr | YoY β 59.73% | QoQ β 26.23%
β’ EBITDA Margin: 4.45% vs 12.04% (YoY), 5.57% (QoQ)
β’ Net Profit: βΉ68.95 Cr | YoY β 55.02% | QoQ β 33.25%
β’ Revenue: βΉ1,752.52 Cr | YoY β 8.93% | QoQ β 7.76%
β’ EBITDA: βΉ78.02 Cr | YoY β 59.73% | QoQ β 26.23%
β’ EBITDA Margin: 4.45% vs 12.04% (YoY), 5.57% (QoQ)
ARSS INFRA β Q2 FY27 (CONSOLIDATED)
β’ Net Loss: βΉ8.07 Cr | Loss narrowed YoY and QoQ
β’ Revenue: βΉ23.11 Cr | YoY β 102.53% | QoQ β 59.05%
β’ EBITDA Loss: βΉ3.71 Cr | Loss narrowed YoY and QoQ
β’ EBITDA Margin: -16.04% vs -39.83% (YoY), -40.43% (QoQ)
β’ Net Loss: βΉ8.07 Cr | Loss narrowed YoY and QoQ
β’ Revenue: βΉ23.11 Cr | YoY β 102.53% | QoQ β 59.05%
β’ EBITDA Loss: βΉ3.71 Cr | Loss narrowed YoY and QoQ
β’ EBITDA Margin: -16.04% vs -39.83% (YoY), -40.43% (QoQ)
β€1
SURAKSHA DIAGNOSTIC β Q2 FY27
β’ Net Profit: βΉ15 Cr | YoY β 69% | QoQ β 16%
β’ Revenue: βΉ99 Cr | YoY β 26% | QoQ β 13%
β’ EBITDA: βΉ35 Cr | YoY β 44% | QoQ β 14%
β’ EBITDA Margin: 35.1% vs 30.6% (YoY), 34.7% (QoQ)
β’ Net Profit: βΉ15 Cr | YoY β 69% | QoQ β 16%
β’ Revenue: βΉ99 Cr | YoY β 26% | QoQ β 13%
β’ EBITDA: βΉ35 Cr | YoY β 44% | QoQ β 14%
β’ EBITDA Margin: 35.1% vs 30.6% (YoY), 34.7% (QoQ)
COVANCE SOFTSOL β Q2 FY27 (CONSOLIDATED)
β’ Net Profit: βΉ6.87 Cr | YoY β 10.62% | QoQ β 45.72%
β’ Revenue: βΉ28.10 Cr | YoY β 15.30% | QoQ β 4.00%
β’ EBITDA: βΉ3.91 Cr | YoY β 54.16% | QoQ β 23.70%
β’ EBITDA Margin: 13.93% vs 25.73% (YoY), 17.52% (QoQ)
β’ Net Profit: βΉ6.87 Cr | YoY β 10.62% | QoQ β 45.72%
β’ Revenue: βΉ28.10 Cr | YoY β 15.30% | QoQ β 4.00%
β’ EBITDA: βΉ3.91 Cr | YoY β 54.16% | QoQ β 23.70%
β’ EBITDA Margin: 13.93% vs 25.73% (YoY), 17.52% (QoQ)
β€1
CENTURY BUSINESS MEDIA β H1 FY27 (STANDALONE)
β’ Net Profit: βΉ3.37 Cr | YoY β 10.88% | QoQ β 33.96%
β’ Revenue: βΉ26.09 Cr | YoY β 21.74% | QoQ β 24.29%
β’ EBITDA: βΉ5.20 Cr | YoY β 9.29% | QoQ β 1,581.90%
β’ EBITDA Margin: 19.94% vs 22.22% (YoY), 1.47% (QoQ)
β’ Net Profit: βΉ3.37 Cr | YoY β 10.88% | QoQ β 33.96%
β’ Revenue: βΉ26.09 Cr | YoY β 21.74% | QoQ β 24.29%
β’ EBITDA: βΉ5.20 Cr | YoY β 9.29% | QoQ β 1,581.90%
β’ EBITDA Margin: 19.94% vs 22.22% (YoY), 1.47% (QoQ)
β€1
MICROSOFT HAS PRESSED WHITE HOUSE TO HALT FCC PLANS TO BAR IMPORTS OF NEW MODELS OF CHINESE OPTICAL TRANSCEIVERS- RTRS
β€1